Alexis, Andrew F, Paul S Yamauchi, Tina Lin, and Gina Martin. “Efficacy, Safety, and Tolerability of a Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination in the Treatment of Moderate-to-Severe Plaque Psoriasis in a Hispanic Population: Post Hoc Analysis of Two Phase 3 Randomized Controlled Trials”. SKIN The Journal of Cutaneous Medicine 3 (November 9, 2019): S28. Accessed July 3, 2024. https://jofskin.org/33014/index.php/skin/article/view/755.